Literature DB >> 10094979

Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men.

J F Colin1, D Cazals-Hatem, M A Loriot, M Martinot-Peignoux, B N Pham, A Auperin, C Degott, J P Benhamou, S Erlinger, D Valla, P Marcellin.   

Abstract

The aim of this study was to assess the influence of human immunodeficiency virus (HIV) infection on chronic hepatitis B. In a series of 132 (65 anti-HIV positive) homosexual non-drug addicted men with chronic hepatitis B, the liver function was assessed with biochemical tests; the degree of hepatitis B virus (HBV) replication was assessed with serum HBV DNA level and with immunoperoxidase staining of hepatitis B core (HBc) antigen on liver specimens; and the severity of liver lesions was assessed with an histology activity index. Anti-HIV-positive and anti-HIV-negative patients were not different for serum aspartate transaminase activity, bilirubin, prothrombin, and histology activity index. Anti-HIV-positive patients had lower serum alanine transaminase activity levels (P =.0001), lower serum albumin levels (P =.0009), and higher serum HBV DNA levels (P =.01). There was a higher prevalence of cirrhosis in anti-HIV-positive patients (P =.04). In homosexual men with chronic hepatitis B, HIV infection is associated with a higher level of HBV replication and a higher risk for cirrhosis without increased liver necrotico-inflammatory process.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10094979     DOI: 10.1002/hep.510290447

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  104 in total

1.  Hepatitis B virus coinfection negatively impacts HIV outcomes in HIV seroconverters.

Authors:  Helen M Chun; Mollie P Roediger; Katherine Huppler Hullsiek; Chloe L Thio; Brian K Agan; William P Bradley; Sheila A Peel; Linda L Jagodzinski; Amy C Weintrob; Anuradha Ganesan; Glenn Wortmann; Nancy F Crum-Cianflone; Jason D Maguire; Michael L Landrum
Journal:  J Infect Dis       Date:  2011-12-05       Impact factor: 5.226

2.  In vitro replication phenotype of a novel (-1G) hepatitis B virus variant associated with HIV co-infection.

Authors:  Liza M Cabuang; Tim Shaw; Margaret Littlejohn; Danni Colledge; Vitini Sozzi; Sally Soppe; Nadia Warner; Alex Thompson; Scott Preiss; Natasha Lam; Renae Walsh; Sharon R Lewin; Chloe L Thio; Gail Matthews; Stephen A Locarnini; Peter A Revill
Journal:  J Med Virol       Date:  2012-08       Impact factor: 2.327

Review 3.  Insights into human immunodeficiency virus-hepatitis B virus co-infection in India.

Authors:  Runu Chakravarty; Ananya Pal
Journal:  World J Virol       Date:  2015-08-12

Review 4.  Hepatitis B virus vaccination in HIV-infected people: A review.

Authors:  François-Xavier Catherine; Lionel Piroth
Journal:  Hum Vaccin Immunother       Date:  2017-02-16       Impact factor: 3.452

5.  Characterization of HIV-HBV coinfection in a multinational HIV-infected cohort.

Authors:  Chloe L Thio; Laura Smeaton; Melissa Saulynas; Hyon Hwang; Shanmugam Saravanan; Shanmugam Saravan; Smita Kulkarni; James Hakim; Mulinda Nyirenda; Hussain S Iqbal; Umesh G Lalloo; Anand S Mehta; Kimberly Hollabaugh; Thomas B Campbell; Shahin Lockman; Judith S Currier
Journal:  AIDS       Date:  2013-01-14       Impact factor: 4.177

6.  Human pegivirus (HPgV) infection in Ghanaians co-infected with human immunodeficiency virus (HIV) and hepatitis B virus (HBV).

Authors:  Kombo F N'Guessan; Ceejay Boyce; Awewura Kwara; Timothy N A Archampong; Margaret Lartey; Kwamena W Sagoe; Ernest Kenu; Adjoa Obo-Akwa; Jason T Blackard
Journal:  Virus Genes       Date:  2018-03-17       Impact factor: 2.332

7.  Rapid loss of vaccine-acquired hepatitis B surface antibody after three doses of hepatitis B vaccination in HIV-infected persons.

Authors:  Masako Mizusawa; David C Perlman; David Lucido; Nadim Salomon
Journal:  Int J STD AIDS       Date:  2013-08-29       Impact factor: 1.359

8.  Hepatitis B Virus-HIV Coinfection: Forgotten but Not Gone.

Authors:  Narayan Dharel; Richard K Sterling
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-12

9.  Augmentation of hepatitis B virus-specific cellular immunity with programmed death receptor-1/programmed death receptor-L1 blockade in hepatitis B virus and HIV/hepatitis B virus coinfected patients treated with adefovir.

Authors:  Amy C Sherman; Nirupama Trehanpati; Marybeth Daucher; Richard T Davey; Henry Masur; Shiv Kumar Sarin; Shyam Kottilil; Anita Kohli
Journal:  AIDS Res Hum Retroviruses       Date:  2013-02-11       Impact factor: 2.205

Review 10.  HIV/HBV coinfection in children and antiviral therapy.

Authors:  Sara A Healy; Sonia Gupta; Ann J Melvin
Journal:  Expert Rev Anti Infect Ther       Date:  2013-03       Impact factor: 5.091

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.